Top Companies in Diabetes Care Drugs Market
This report lists the top Diabetes Care Drugs companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Diabetes Care Drugs industry.
-
Novo Nordisk
-
Sanofi
-
AstraZeneca
-
Boehringer Ingelheim
-
Eli Lilly and Company
*Disclaimer: Top companies sorted in no particular order
Diabetes Care Drugs Market Concentration
Diabetes Care Drugs Company List
Novo Nordisk
Sanofi
Eli Lilly and Company
Biocon
AstraZeneca
Bristol Myers Squibb
Boehringer Ingelheim
Mylan
Pfizer
Johnson & Johnson
Merck & Co.
Novartis
Astellas Pharma
Teva Pharmaceuticals
Company Share Analysis
Insulin Drugs
Novo Nordisk
Sanofi
Eli Lilly and Company
Others
Specific to Diabetes Care Drugs Market
Competitive Landscape Report Includes
Company Profiles (includes Global Level Overview, Market Level Overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and Analysis of Recent Developments). Key Strategic Moves, Market Share Analysis, Company Landscape, and List of Companies.
Diabetes Care Drugs Market Companies Summary
The diabetes care drugs market saw significant changes due to the COVID-19 pandemic, highlighting the potential for advancements in diabetes care. These advancements include virtual consultations between healthcare professionals and individuals with diabetes and the use of diabetes technology. The crisis led to increased interest in remote care, removal of regulatory barriers, and the use of personal blood glucose meters and continuous glucose monitoring devices in hospitals. The high prevalence of diabetes among individuals hospitalized with COVID-19 emphasized the significance of diabetes care devices. The market is moderately fragmented, with a few significant and generic players dominating. The insulin drugs and Sglt-2 drugs market are dominated by a few major players, while the market for oral drugs comprises more generic players. The intensity of competition among the players is high, with each player striving to develop new drugs and offer them at competitive pricing. To increase their market shares, players are tapping into new markets, especially emerging economies where the demand is very high compared to the supply.
Explore MoreDiabetes Care Drugs Companies - Table of Contents
-
1. COMPETITIVE LANDSCAPE
-
1.1 Company Profiles
-
1.1.1 Novo Nordisk
-
1.1.2 Sanofi
-
1.1.3 Eli Lilly and Company
-
1.1.4 Biocon
-
1.1.5 AstraZeneca
-
1.1.6 Bristol Myers Squibb
-
1.1.7 Boehringer Ingelheim
-
1.1.8 Mylan
-
1.1.9 Pfizer
-
1.1.10 Johnson & Johnson
-
1.1.11 Merck & Co.
-
1.1.12 Novartis
-
1.1.13 Astellas Pharma
-
1.1.14 Teva Pharmaceuticals
-
- *List Not Exhaustive
-
1.2 Company Share Analysis
-
1.2.1 Insulin Drugs
-
1.2.1.1 Novo Nordisk
-
1.2.1.2 Sanofi
-
1.2.1.3 Eli Lilly and Company
-
1.2.1.4 Others
-
-
-
Diabetes Care Drugs Companies FAQs
Who are the key players in Diabetes Care Drugs Market?
Novo Nordisk, Sanofi, AstraZeneca, Boehringer Ingelheim and Eli Lilly and Company are the major companies operating in the Diabetes Care Drugs Market.